Li Y - Search Results

1

HOXA4-Dependent Transcriptional Activation of AXL Promotes Cisplatin- Resistance in Lung Adenocarcinoma Cells.

Yu S, Ren H, Li Y, Liang X, Ning Q, Chen X, Chen M, Hu T. Yu S, et al. Among authors: li y. Anticancer Agents Med Chem. 2018;18(14):2062-2067. doi: 10.2174/1871520619666181203110835. Anticancer Agents Med Chem. 2018. PMID: 30501603

2

Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.

Li Y, Hu T, Chen T, Yang T, Ren H, Chen M. Li Y, et al. Oncol Rep. 2018 Feb;39(2):565-572. doi: 10.3892/or.2017.6111. Epub 2017 Nov 24. Oncol Rep. 2018. PMID: 29207165

3

Loss of Beclin1 Expression and Nrf2 Overexpression are Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer.

Yu S, Cheng C, Wang J, Wang J, Qu Z, Ren H, Li Y, Ning Q, Chen M, Hu T. Yu S, et al. Among authors: li y. Anticancer Agents Med Chem. 2018;18(12):1680-1687. doi: 10.2174/1871520618666180830110700. Anticancer Agents Med Chem. 2018. PMID: 30160218

4

PDK2 induces cisplatin-resistance in lung adenocarcinoma via transcriptional regulation of CNNM3.

Hu T, Yu S, Li Y, Ren H, Ning Q, Wang J, Liang X, Li M. Hu T, et al. Among authors: li y, li m. J Drug Target. 2019 Apr;27(4):460-465. doi: 10.1080/1061186X.2018.1550648. Epub 2018 Dec 4. J Drug Target. 2019. PMID: 30457021

5

PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1.

Yu S, Li Y, Ren H, Zhou H, Ning Q, Chen X, Hu T, Yang L. Yu S, et al. Among authors: li y. Cancer Chemother Pharmacol. 2021 Feb;87(2):207-215. doi: 10.1007/s00280-020-04188-9. Epub 2020 Nov 21. Cancer Chemother Pharmacol. 2021. PMID: 33221963

6

miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer.

Chen T, Ren H, Thakur A, Yang T, Li Y, Zhang S, Wang T, Chen M. Chen T, et al. Among authors: li y. Biomed Pharmacother. 2017 Feb;86:248-253. doi: 10.1016/j.biopha.2016.12.007. Epub 2016 Dec 19. Biomed Pharmacother. 2017. PMID: 28006750

7

Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2.

Li Y, Wang D, Ren H, Feng W. Li Y, et al. Thorac Cancer. 2020 Mar;11(3):686-692. doi: 10.1111/1759-7714.13318. Epub 2020 Feb 7. Thorac Cancer. 2020. PMID: 32031335 Free PMC article.

8

LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis.

Chen TJ, Gao F, Yang T, Li H, Li Y, Ren H, Chen MW. Chen TJ, et al. Among authors: li y, li h. Cancer Manag Res. 2020 Jun 9;12:4379-4390. doi: 10.2147/CMAR.S244573. eCollection 2020. Cancer Manag Res. 2020. Retraction in: Cancer Manag Res. 2024 Jan 22;16:65-66. doi: 10.2147/CMAR.S460239 PMID: 32606933 Free PMC article. Retracted.

9

Correction to: PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1.

Yu S, Li Y, Ren H, Zhou H, Ning Q, Chen X, Hu T, Yang L. Yu S, et al. Among authors: li y. Cancer Chemother Pharmacol. 2021 Sep;88(3):563. doi: 10.1007/s00280-021-04275-5. Cancer Chemother Pharmacol. 2021. PMID: 33856532 No abstract available.

10

MicroRNA-665 facilitates cell proliferation and represses apoptosis through modulating Wnt5a/β-Catenin and Caspase-3 signaling pathways by targeting TRIM8 in LUSC.

Chen TJ, Zheng Q, Gao F, Yang T, Ren H, Li Y, Chen MW. Chen TJ, et al. Among authors: li y. Cancer Cell Int. 2021 Apr 15;21(1):215. doi: 10.1186/s12935-021-01913-z. Cancer Cell Int. 2021. PMID: 33858426 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239,969 results

Search Page

Filters